Given recent data arguing that the METTL3-mediated addition of m6A residues to mRNAs also promotes the uncontrolled growth of acute myeloid leukemia cells [36], such a compound might also prove useful in the treatment of certain types of cancer. This evidence concerns the gene METTL3 and cancer.